Free calculator · No signup
Build vs Buy — Clinical Trials Operations
Weigh SaaS subscriptions against a custom build for Clinical Trials Operations — see the multi-year total cost of ownership and which path wins.
What this means for Clinical Trials Operations
- Patient recruitment is the single biggest cause of trial delay; sites enroll well below plan and the sponsor cost-of-delay runs into seven-figures-per-day on Phase III studies.
- Protocol amendments are frequent, expensive, and operationally disruptive — every amendment ripples through CTMS, EDC, eConsent, and site training.
- Regulatory and quality discipline (GCP, ICH, 21 CFR Part 11, EU CTR) is non-negotiable and the audit-and-evidence workflow is sustained.
Where it pays to act
- Patient-recruitment AI — site-and-cohort identification, EHR-and-claims-based outreach, and pre-screening automation.
- Protocol-design and amendment-impact AI — protocol complexity scoring, amendment-impact simulation, and operational-feasibility prediction.
Adjust the inputs to match your Clinical Trials Operations context.
Total cost of ownership
SaaS total (3yr)
₹19.9 L
Custom build total
₹21.8 L
Difference (cheaper to buy)
₹1.89 L
Breakeven
—
What this means
A hybrid path fits best.
For Clinical Trials Operations, the gap is ₹1.89 L over 3 years — close enough that a hybrid approach (buy core, build differentiating layers) often wins.
Project inquiry
Tell us about your project.
No sign-up, and nothing is stored. Submitting opens your email or WhatsApp with the details pre-filled and ready to send.
Build vs buy — summary
More tools for Clinical Trials Operations
AI Readiness Audit
Score process clarity, data readiness, team adoption, and guardrails before investing in AI.
Sample output
67/100 → pilot with control, not full rollout
Digital Transformation Audit
Assess KPI clarity, reporting, tool alignment, ownership, and automation maturity.
Sample output
52/100 → foundation gaps in metrics and handoffs
Supplier Cost Audit
Assess supplier diversification, cost visibility, pricing competitiveness, and negotiation strength.
Sample output
65/100 → 3-5% cost reduction opportunity
Cost of Manual Work — Clinical Trials Operations
Quantify the annual cost and people-weeks lost to repetitive manual work — and the automation payback.
Revenue Leak — Clinical Trials Operations
See how much revenue leaks every month from a low conversion rate — and what closing the gap to your target is worth.
AI Readiness Audit — Clinical Trials Operations
Score whether your team has the strategy, data, process, and guardrails to deploy practical AI — framed around the highest-ROI use cases for your sector.